Aroa Biosurgery Income Statement

Financials in millions NZD. Fiscal year is April - March.

Millions NZD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	90.4	84.7	69.07	63.36	39.68	22.34
Revenue Growth (YoY)	18.40%	22.63%	9.01%	59.68%	77.60%	-10.90%
Cost of Revenue	13.5	12.08	10.09	9.88	9.38	6.82
Gross Profit	76.9	72.61	58.97	53.48	30.3	15.52
Selling, General & Admin	68.97	67.05	62.15	47.71	30.71	21.76
Research & Development	8.26	9.57	9.16	10.61	8.35	6.43
Other Operating Expenses	-0.95	-1.08	-1.66	-1.73	-1.12	-2.68
Operating Expenses	76.27	75.53	69.64	56.59	37.95	25.5
Operating Income	0.63	-2.92	-10.67	-3.11	-7.64	-9.98
Interest Expense	-0.43	-0.48	-0.49	-0.38	-1.15	-1.91
Interest & Investment Income	0.76	1.06	1.8	1.32	0.4	0.15
Currency Exchange Gain (Loss)	-2.32	-0.9	-1.05	1.8	0.13	0.65
Other Non Operating Income (Expenses)	-0.01	-0.01	-0.01	-0.01	-0	-0
EBT Excluding Unusual Items	-1.38	-3.25	-10.43	-0.38	-8.26	-11.09
Other Unusual Items	-	-	-	-	-	-8.01
Pretax Income	-1.38	-3.25	-10.43	-0.38	-8.26	-19.1
Income Tax Expense	0.44	0.56	0.2	0.01	0.13	0.11
Net Income	-1.82	-3.81	-10.63	-0.4	-8.39	-19.21
Net Income to Common	-1.82	-3.81	-10.63	-0.4	-8.39	-19.21
Shares Outstanding (Basic)	345	345	344	343	342	300
Shares Outstanding (Diluted)	345	345	344	343	342	300
Shares Change (YoY)	0.19%	0.31%	0.27%	0.22%	13.90%	10620.95%
EPS (Basic)	-0.01	-0.01	-0.03	-0.00	-0.02	-0.06
EPS (Diluted)	-0.01	-0.01	-0.03	-0.00	-0.02	-0.06
Free Cash Flow	5.04	-4.88	-10.9	-9.8	-15.98	-6.27
Free Cash Flow Per Share	0.01	-0.01	-0.03	-0.03	-0.05	-0.02
Gross Margin	85.07%	85.73%	85.39%	84.40%	76.37%	69.48%
Operating Margin	0.70%	-3.45%	-15.45%	-4.91%	-19.26%	-44.66%
Profit Margin	-2.01%	-4.50%	-15.39%	-0.63%	-21.13%	-85.98%
Free Cash Flow Margin	5.58%	-5.76%	-15.78%	-15.47%	-40.27%	-28.07%
EBITDA	3.82	0.26	-7.4	-0.08	-5.29	-7.67
EBITDA Margin	4.23%	0.30%	-10.71%	-0.13%	-13.32%	-34.33%
D&A For EBITDA	3.19	3.17	3.28	3.03	2.36	2.31
EBIT	0.63	-2.92	-10.67	-3.11	-7.64	-9.98
EBIT Margin	0.70%	-3.45%	-15.45%	-4.91%	-19.26%	-44.66%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.